Literature DB >> 15664230

Chronic kidney disease: the global challenge.

A Meguid El Nahas1, Aminu K Bello.   

Abstract

The worldwide rise in the number of patients with chronic kidney disease (CKD) and consequent end-stage renal failure necessitating renal replacement therapy is threatening to reach epidemic proportions over the next decade, and only a small number of countries have robust economies able to meet the challenges posed. A change in global approach to CKD from treatment of end-stage renal disease (ESRD) to much more aggressive primary and secondary prevention is therefore imperative. In this Seminar, we examine the epidemiology of CKD worldwide, with emphasis on early detection and prevention, and the feasibility of methods for detection and primary prevention of CKD. We also review the risk factors and markers of progressive CKD. We explore current understanding of the mechanisms underlying renal scarring leading to ESRD to inform on current and future interventions as well as evidence relating to interventions to slow the progression of CKD. Finally, we make strategic recommendations based on future research to stem the worldwide growth of CKD. Consideration is given to health economics. A global and concerted approach to CKD must be adopted in both more and less developed countries to avoid a major catastrophe.

Entities:  

Mesh:

Year:  2005        PMID: 15664230     DOI: 10.1016/S0140-6736(05)17789-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  340 in total

1.  Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury.

Authors:  Bing Li; Amy Cohen; Thomas E Hudson; Delara Motlagh; David L Amrani; Jeremy S Duffield
Journal:  Circulation       Date:  2010-05-10       Impact factor: 29.690

2.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

3.  Cost-effectiveness of chronic kidney disease mass screening test in Japan.

Authors:  Masahide Kondo; Kunihiro Yamagata; Shu-ling Hoshi; Chie Saito; Koichi Asahi; Toshiki Moriyama; Kazuhiko Tsuruya; Hideaki Yoshida; Kunitoshi Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2011-12-14       Impact factor: 2.801

Review 4.  Epidemiology of hypertensive kidney disease.

Authors:  Suneel Udani; Ivana Lazich; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2010-11-16       Impact factor: 28.314

5.  Diabetes and hypertension have become leading causes of CKD in Chinese elderly patients: a comparison between 1990-1991 and 2009-2010.

Authors:  Yali Cao; Wenge Li; Guannan Yang; Yutian Liu; Xin Li
Journal:  Int Urol Nephrol       Date:  2012-05-31       Impact factor: 2.370

6.  Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis.

Authors:  Raja Zabaneh; Simon D Roger; Mohamed El-Shahawy; Michael Roppolo; Grant Runyan; Janet O'Neil; Ping Qiu
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

7.  Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.

Authors:  Justyna Siwy; Joost P Schanstra; Angel Argiles; Stephan J L Bakker; Joachim Beige; Petr Boucek; Korbinian Brand; Christian Delles; Flore Duranton; Beatriz Fernandez-Fernandez; Marie-Luise Jankowski; Mohammad Al Khatib; Thomas Kunt; Maria Lajer; Ralf Lichtinghagen; Morten Lindhardt; David M Maahs; Harald Mischak; William Mullen; Gerjan Navis; Marina Noutsou; Alberto Ortiz; Frederik Persson; John R Petrie; Johannes M Roob; Peter Rossing; Piero Ruggenenti; Ivan Rychlik; Andreas L Serra; Janet Snell-Bergeon; Goce Spasovski; Olivera Stojceva-Taneva; Matias Trillini; Heiko von der Leyen; Brigitte M Winklhofer-Roob; Petra Zürbig; Joachim Jankowski
Journal:  Nephrol Dial Transplant       Date:  2014-03-02       Impact factor: 5.992

Review 8.  Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Authors:  Nikolaus Marx; Heidi Noels; Joachim Jankowski; Jürgen Floege; Danilo Fliser; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-05-04       Impact factor: 5.460

9.  Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease.

Authors:  Mark M Mitsnefes; Thelma S Kathman; Jaya Mishra; Janis Kartal; Philip R Khoury; Thomas L Nickolas; Jonathan Barasch; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2006-10-27       Impact factor: 3.714

10.  Macrophage A2A Adenosine Receptors Are Essential to Protect from Progressive Kidney Injury.

Authors:  Luan D Truong; Jessica Trostel; Rachel McMahan; Jiang-Fan Chen; Gabriela E Garcia
Journal:  Am J Pathol       Date:  2016-08-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.